Australia Warns Against Counterfeit Rabies Vaccine in India: What Advisory Says and How 'Abhayrab' Manufacturer Reacted
Australian health authorities caution on potential counterfeit rabies vaccines in India since Nov 2023; manufacturer disputes broad alert, citing a single isolated batch in Jan 2025.
10 Articles
10 Articles
Alert does not reflect current situation: Indian Immunologicals on fake rabies vaccine claims
New Delhi: Dismissing fears over counterfeit antirabies vaccines, Indian Immunologicals Limited (IIL) has refuted an Australian alert that warned of fake Abhayrab doses in India, saying the claims do...
Abhayrab Manufacturer IIL Issues Clarification After Australian Authorities Issue Warning on Counterfeit Rabies Vaccine in India
ATAGI advised Australian travellers who received the Abhayrab vaccine in India after November 1, 2023, to restart immunisation due to counterfeit concerns. The manufacturer, IIL, clarified that the issue involves a specific batch and urged ATAGI to reconsider its advisory to avoid public anxiety.
Indian Immunologicals refutes Australian advisory on rabies vaccine, calls it ‘over-cautionary and misplaced'
IIL clarifies that the issue pertains only to Batch No. KA24014 and requests a review of the Australian Government's advisory to prevent public.Abhayrab vaccine, Indian Immunologicals Limited, counterfeit rabies vaccine India, rabies vaccine advisory, ATAGI vaccine warning, IIL vaccine clarification, vaccine safety India, Batch No. KA24014, rabies vaccine counterfeit batch, travel vaccine advisory India, vaccine quality control India, understand…
Australia warns against counterfeit rabies vaccine in India: What advisory says and how 'Abhayrab' manufacturer reacted
ATAGI advised Australian travelers who received the Abhayrab vaccine in India after November 1, 2023, to restart immunisation due to counterfeit concerns. The manufacturer, IIL, clarified that the issue involves a specific batch and urged ATAGI to reconsider its advisory to avoid public anxiety.
Coverage Details
Bias Distribution
- 43% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium







